Evonik
Thursday, 2024-12-05 - Wednesday, 2024-10-23

Drug Delivery Day: Designing and developing a successful formulation

Sorry! This seminar has already taken place. Please see our event calendar for upcoming events.
Back to workshop overview

Overview

Overview

Evonik Health Care is excited to present our first ever full-day Drug Delivery workshop! Focusing on both oral and parenteral technologies, Evonik’s team has created an agenda full of everything you need to know when designing your formulation.

In this one-day workshop, Evonik’s Drug Delivery experts will share their experiences and insights on the discovery and development of oral formulations, long-acting injectables and RNA-based therapies and mRNA vaccines. As a CDMO partner offering end-to-end solutions, Evonik has decades of experience and expertise in every step of the manufacturing process, including route scouting, process development and optimization, purification, isolation, characterization, scale-up, and commercialization.

[F]This workshop will feature presentations on:[F]
  • the use and application of EUDRAGIT®® polymers and EUDRATEC®® technologies in delayed release, sustained release, controlled release, taste masking, and moisture protection,
  • current advances in leveraging novel lipids, such as randomized PEGs (rPEGs) in LNP-based delivery systems,
  • GMP manufacturing considerations for both parenteral excipients and drug products, focusing on product-by-process manufacturing, ocular implants, microparticles and nanoparticles.

[F]Key learnings for participants[F]
  • Introduction to capabilities necessary to support oral and parenteral development and manufacturing
  • Understanding how to best use the EUDRAGIT®® and EUDRATEC®®
  • Technologies for your oral formaultions
  • Brief history of long-acting polymeric injectable drug products on the market, including microparticles and implants
  • Custom polymer and lipid synthesis, parenteral drug services for formulations
  • And more!

Agenda

08:30 | Registration and Breakfast​

09:00 | Welcome and Introduction

09:30 | Overview of EUDRAGIT®® ​

10:00 | Solubility Enhancement of Poorly Soluble Drugs Using EUDRAGIT®® Polymeric Excipient & EUDRATEC®® SoluFlow – A Free-Flowing Amorphous Solid Dispersion Technology
Dr. Irfan Syed
Associate Director, FAS
Evonik Health Care

10:30 | Coffee Break & Networking

11:00 |Customized Release With  EUDRATEC®® Technologies
Dr. Manish Rane
Associate Director, Technical Sales
Evonik Health Care

11:30 | EUDRACAP®®  ready-to-fill Capsules Enhance Functional Performance
Dr. Kamlesh Oza
Head of Technical Sales NA, Formulation & Application Services
Evonik Health Care

12:00 | Oral Formulations Q&A

12:15 | Lunch and Networking

1:15 | Long-acting Formulations – Polymeric Microparticles and Implants
Dr. Tom Tice
Senior Director, Technical Marketing
Evonik Health Care

2:00 | Choosing the Right Bioresorbable Polymer for your Formulation
Dr. Manish Rane
Associate Director, Technical Sales
Evonik Health Care

2:15 | Custom Formulation Development and Production
Dr. Tom Tice
Senior Director, Technical Marketing
Evonik Health Care

2:45 | Coffee Break and Networking

3:00 | Lipids, Learnings & Future Opportunities

3:30 | LNP Mixing Technologies
Dr. Michael Parr
Director Formulation and Process Development
Evonik Health Care

4:15 | Parenteral Formulations Q&A

4:30 | Wrap Up

5:00 | Happy Hour Reception

Experts

Dr. Thomas R. Tice
Senior Director Technical Global Technical Marketing
Evonik Health Care

Vita
Thomas Tice is internationally recognized for his research and product development of complex parenteral, drug delivery dosage forms based on bioabsorbable polymer excipients. He is known for his accomplishments involving injectable, extended-release microparticles made with bioabsorbable lactide/glycolide polymers designed for systemic and local drug delivery. He was a team leader and core inventor to develop the first commercial, injectable, extended-release microparticle product. This product, a one-month LHRH formulation indicated for the treatment of prostate cancer (Decapeptyl® SR), is still on the market today. He has also served on various US Pharmacopeia expert committees for 17 years, and is currently on the General Chapters Dosage Forms Expert Committee and Excipient Joint Committee.

At Evonik, Dr. Tice, provides scientific support to Evonik’s innovation, sales, product development, research, intellectual property and M&A teams. He earned his BSc in Chemistry and PhD in Biophysics from Syracuse University, New York. He held a postdoctoral fellow position at the University of Alabama at Birmingham (UAB) in Microbiology. He holds 48 US patents with many foreign equivalents and has more than 180 publications, presentations, and invited lectures to his credit. He flew experiments on two Space Shuttle flights.
Dr. Michael Parr
Director Formulation and Process Development
Evonik Health Care

Vita
Dr. Michael “Mike” Parr joined the Production & Technology team of Evonik’s Health Care business line in 2021 as director of formulations and process development for the Vancouver site. Mike is responsible for leading multifunctional teams and ensuring the successful execution of a portfolio of complex customer-funded development programs as part of the parenteral drug delivery solutions business.

Mike has more than 20 years of experience in the pharmaceutical industry including roles at Sitka Biopharma, CDRD Ventures Inc., Angiotech and Biogen Idec. His areas of expertise include liposomal drug delivery systems, formulation, molecular biology, GLP, GMP activities and clinical development. Mike holds a B.Sc. Honours and Ph.D. in Biochemistry and Molecular Biology from The University of British Columbia in the laboratory of Dr. Pieter Cullis and he completed post-doctoral studies at Harvard Medical School.
Dr. Kamlesh Oza
Head of Technical & Formulation and Application Services for North America
Evonik Health Care

Dr. Manish Rane
Associate Director Technical Sales
Evonik Health Care

Irfan Syed
Associate Director Formulation & Application Services
Evonik Health Care

Details

Participation fee:
$50
City/State:
La Jolla, CA
Country:
USA
Seminar language:
English

Venue

The workshop will take place at:
San Diego Marriott La Jolla Hotel,
4240 La Jolla Village Drive,
La Jolla, CA 92037

Questions?

Emily Peters
Manager Regional Marketing, North America
Evonik Health Care
+1 732 981 5145 E-Mail